Analyst David Westenberg works at PIPER SANDLER and is focused on the Healthcare sector with 162 price targets and ratings documented since 2016 spanning on 17 stocks. Previously, David Westenberg worked at GUGGENHEIM, C. L. KING. Analyst's average stock valuation to be materialised ratio is 34.92% with an average time for price targets to be met of 61.41 days.
Most recent stock forecast was given on OCX, OncoCyte Corporation at 18-Nov-2022.
David Westenberg best performing recommendations are on OCX (ONCOCYTE CORPORATION).
The best stock recommendation documented was for OCX (ONCOCYTE CORPORATION) at 5/16/2022. The price target of $1 was fulfilled within 8 days with a profit of $0.16 (13.79%) receiving and performance score of 17.24.
Average potential price target upside
